Skip to content

KORU Medical Systems KRMD Non Us — Revenue

Similar metrics at other companies

TransMedics Group, Inc. logo
TMDXNon Us — Revenue
$5.65M+38.9%
Solesence, Inc. Common Stock logo
SLSNNon Us — Revenue
$913K-8.1%
III
IIINNon Us — Revenue
$541K-67.6%
ROC
ROCNon Us — Revenue
$273.88K-42.7%
FAT
FATNNon Us — Revenue
$78.54K-40.1%
ePlus logo
PLUSNon Us — Revenue
$23.17M+8.6%

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's non us — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's non us — revenue?
KORU Medical Systems (KRMD) reported non us — revenue of $3.33M in Q1 2026.
How has KORU Medical Systems's non us — revenue changed year-over-year?
KORU Medical Systems's non us — revenue increased by 36.9% year-over-year, from $2.43M to $3.33M.
What is the long-term trend for KORU Medical Systems's non us — revenue?
Over 4 years (2021 to 2025), KORU Medical Systems's non us — revenue has grown at a 28.4% compound annual growth rate (CAGR), from $4M to $10.89M.
What does non us — revenue mean?
This metric represents the total gross revenue generated by the company from operations and sales conducted outside of its primary domestic market. It serves as a key indicator of the company's international market penetration and the success of its global distribution strategy for medical infusion devices. Tracking this figure helps investors assess the company's geographic diversification and exposure to international regulatory and economic environments.